Clinical Trial Update: Intravenous Palonosetron With Radiotherapy and Concomitant Temozolomide [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating intravenous palonosetron with radiotherapy and temozolomide in malignant glioma has completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Drugs mentioned

• Palonosetron (palonosetron)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Duke University | Conditions: Malignant Glioma | Phase 2 | Status: COMPLETED | Results posted: 2014-04-01